Peregrine Capital Management LLC Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Peregrine Capital Management LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% in the 4th quarter, Holdings Channel reports. The firm owned 129,988 shares of the medical equipment provider’s stock after selling 6,242 shares during the period. Intuitive Surgical accounts for 2.0% of Peregrine Capital Management LLC’s portfolio, making the stock its 6th biggest holding. Peregrine Capital Management LLC’s holdings in Intuitive Surgical were worth $67,849,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical in the third quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 0.7 %

Shares of NASDAQ:ISRG opened at $595.55 on Tuesday. The business’s 50 day moving average is $559.48 and its 200 day moving average is $520.19. The stock has a market cap of $212.12 billion, a P/E ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.